Stryker develops and manufactures orthopedic implants for joint replacements and trauma, along with medical and surgical equipment such as power tools, stretchers, endoscopy systems, and patient handling devices. Its products are used primarily by hospitals, surgeons, and emergency responders in over 75 countries to support surgical procedures, critical care, and mobility. The company maintains a broad portfolio across orthopedics, neurotechnology, and spine segments, supported by ongoing product innovation and acquisitions.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 6,022 | — | 884 | — |
| Q3 2025 | 6,057 | — | 859 | — |
| Q4 2025 | 7,171 | — | 849 | — |
| Q1 2026 | 6,020 | — | 745 | — |
| Q2 2026 | 6,589 | 9.4% | 1,276 | 44.3% |
All markets — KeepWinning global stock screener
Other companies on NYSE: The Bank of Nova Scotia (BNS), Equinor ASA (EQNR), Canadian Natural Resources Limited (CNQ), Lowe's Companies, Inc. (LOW), Spotify Technology S.A. (SPOT), Snowflake Inc. (SNOW)